Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the forefront of RNA biology, utilizing massively parallel reporters to identify sequence and structural elements that regulate mRNA stability and translation. In this role, the candidate will leverage
-
extensive cell tracking studies with massive parallel sequencing and molecular manipulations to gain insights into regulatory mechanisms whose appropriate targeting could impose regenerative traits to mammals
-
PhD degree in Computer Science, Physics or a related field Experience with parallel programming models Strong programming skills in C/C++ and/or Python Knowledge of distributed memory programming with
-
(including patent-relevant work) What will you bring? A PhD in bioinformatics, computational biology or a parallel field such as immunology with demonstrated experience in bioinformatics An understanding
-
contribute to standardisation documents Present findings at international events The research activities will be hosted by the Parallel Computing and Optimisation Group (PCOG) at SnT, headed by Dr. Grégoire
-
technical committees, consider the usage of standards, and contribute to standardisation documents Present findings at international events The research activities will be hosted by the Parallel Computing and
-
relevant technical committees, consider the usage of standards, and contribute to standardisation documents Present findings at international events The research activities will be hosted by the Parallel
-
experiment operation in 2028. Emphasis has to be put on the application of the software in real-time, making use of massive parallelism on CPU and/or on GPU. Your profile: From the applicant, we expect a
-
amounts to 720 000 SEK in total (360 000 SEK annual average) and is usually paid out as four separate payments during scholarship period. This project is running in parallel with another larger project with
-
treatment options for currently incurable disorders. A core strength of the Wolfson SPaRC is the parallel use of pre-clinical cellular, ex-vivo and in vivo models, alongside our world-leading expertise in